share_log

Insurance Giant Humana Stock Tumbles 9% After Q2 Earnings Beat, Issues Sub Par Profit Outlook

Insurance Giant Humana Stock Tumbles 9% After Q2 Earnings Beat, Issues Sub Par Profit Outlook

保险巨头哈门那股票在Q2盈利超预期后下跌9%,发出次差利润前景。
Benzinga ·  07/31 10:27

Wednesday,$Humana (HUM.US)$ posted second-quarter adjusted EPS of $6.96, down from $8.94 a year ago, beating the consensus of $5.85.

星期三,$哈门那 (HUM.US)$ 第二季度每股收益为$6.96,低于去年的$8.94,超过预期的$5.85。

"This outperformance was driven by higher than anticipated revenue in our MA business, combined with favorable claims development and lower than planned administrative expenses, some of which is considered timing in nature," the company said.

公司表示:“这一业绩优于预期,主要是因为医疗保险业务的收入高于预期,加上有利的索赔处理和计划内的较低行政费用,其中一部分被认为是计时性质。”

The company reported revenues of $29.54 billion, up from $26.75 billion, beating the consensus of $28.51 billion.

公司报告的营业收入为$295.4亿,高于267.5亿,超过预期的285.1亿。

The sales increased on higher per-member Medicare premiums, and Medicare Advantage and state-based contracts membership growth.

销售额增加主要是由于每位医保成员的保费增加,以及医疗保险业务和州级协议的成员增长。

"Revenue for the quarter was slightly favorable to expectations driven by the higher than anticipated membership growth, along with slightly higher than anticipated member risk scores," Humana's management team said in prepared remarks.

哈门那的管理团队在准备好的声明中表示:“本季度的营收略高于预期,主要是由于预期之外的会员增长,以及略高于预期的会员风险评分。”

Humana ended the second quarter with 16.3 million in total medical membership, down from 17.13 million a year ago. Medicare Advantage membership reached 5.62 million, up from 5.27 million a year ago.

截至第二季度末,哈门那总的医疗保险成员数为1630万,低于去年的1713万。医疗保险业务则有562万成员,高于去年的527万。

The benefit ratio increased to 89.0% from 86.3% a year ago, positively impacted by favorable claims development and slightly higher than anticipated member risk scores. This favorability was partially offset by higher MA net inpatient costs.

受有利的索赔处理和略高于预期的会员风险评分影响,利润比率从去年的86.3%上升至89.0%。这一利好情况被较高的医疗保险住院治疗净费用所部分抵消。

Humana experienced favorable claims development in the quarter, primarily due to lower inpatient unit costs, observation stays, and higher claim recoveries.

本季度哈门那的索赔处理情况较为有利,主要是由于住院单位成本减少、观察逗留时间减少以及索赔收回增加。

This favorability was partially offset by higher-than-anticipated inpatient admissions, which increased above expectations in the back half of the quarter.

然而,本季度住院次数高于预期,上半季度比预期更高。

Humana raised its 2024 individual Medicare Advantage annual membership growth expectations by 75,000 to a new target of 225,000.

哈门那将其2024年个人医保年度成员增长预期上调75,000,达到新目标225,000。

The company reaffirms 2024 adjusted EPS of ~$16.00 versus the consensus of $20.31. Humana expects a 2024 insurance segment benefit ratio of approximately 90%.

公司重申2024年每股收益目标为~$16.00,预测值为$20.31。哈门那预计2024年保险业务利润率为约90%。

"Looking ahead to 2025, we are focused on driving growth and further productivity across the enterprise to support sustainable earnings growth," Humana said.

哈门那表示:“展望2025年,我们专注于推动企业增长和提高生产率,支持可持续盈利增长。”

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发